Nuzenio

Immunotherapy Startup Attovia

Immunotherapy Startup Attovia news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 08:26:00 GMTImmunotherapy Startup Attovia Lists on Nasdaq: IPO Raises $289 Million, First-Day Market Cap Tops $900 Million - finance.biggo.com
Wed, 05 Aug 2026 16:19:45 GMTAttovia adds to biotech IPO momentum with $289M offering - BioPharma Dive
Wed, 05 Aug 2026 04:37:18 GMTSaint Jean Groupe IFRS net loss narrows to EUR 206,000 in H1 FY26; revenue rises 7.79% to EUR 63.3 million vs H1 FY25 - Bitget
Tue, 04 Aug 2026 20:21:13 GMTBiotechnology IPO boom continues! Goldman Sachs-backed immunotherapy startup Attovia (ATTO.US) raises $289 millions in IPO, to be listed on Nasdaq tonight - Bitget
Mon, 03 Aug 2026 07:00:00 GMTChiron Real Estate names Matthew Whitlock chief investment officer - Bitget
Mon, 03 Aug 2026 07:00:00 GMTSpace Asset Acquisition net income rises to $1.86 million in Q2 2026 - Bitget

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Immunotherapy Startup Attovia.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.